Omar Hikmat

566 total citations
20 papers, 281 citations indexed

About

Omar Hikmat is a scholar working on Molecular Biology, Clinical Biochemistry and Genetics. According to data from OpenAlex, Omar Hikmat has authored 20 papers receiving a total of 281 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 6 papers in Clinical Biochemistry and 4 papers in Genetics. Recurrent topics in Omar Hikmat's work include Mitochondrial Function and Pathology (10 papers), Metabolism and Genetic Disorders (6 papers) and Coenzyme Q10 studies and effects (3 papers). Omar Hikmat is often cited by papers focused on Mitochondrial Function and Pathology (10 papers), Metabolism and Genetic Disorders (6 papers) and Coenzyme Q10 studies and effects (3 papers). Omar Hikmat collaborates with scholars based in Norway, United Kingdom and Finland. Omar Hikmat's co-authors include Laurence A. Bindoff, Charalampos Tzoulis, Eylert Brodtkorb, Claus Klingenberg, Tom Eichele, Pirjo Isohanni, Niklas Darín, I.F.M. de Coo, Johanna Uusimaa and Shamima Rahman and has published in prestigious journals such as SHILAP Revista de lepidopterología, Neurology and International Journal of Molecular Sciences.

In The Last Decade

Omar Hikmat

17 papers receiving 276 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Omar Hikmat Norway 9 234 128 37 28 27 20 281
Benjamin O’Callaghan United Kingdom 7 81 0.3× 59 0.5× 35 0.9× 16 0.6× 7 0.3× 11 162
Katarzyna Kuśmierska Poland 8 110 0.5× 71 0.6× 22 0.6× 41 1.5× 4 0.1× 20 219
Koujyu Katayama Japan 7 296 1.3× 191 1.5× 29 0.8× 59 2.1× 2 0.1× 9 385
Livia Pisciotta Italy 9 102 0.4× 23 0.2× 24 0.6× 8 0.3× 6 0.2× 22 166
Robert W. Taylor United Kingdom 4 262 1.1× 155 1.2× 47 1.3× 34 1.2× 2 0.1× 5 311
Albert Z. Lim United Kingdom 7 157 0.7× 105 0.8× 25 0.7× 23 0.8× 2 0.1× 13 205
Juan Bautista Lorite Spain 4 169 0.7× 56 0.4× 10 0.3× 24 0.9× 20 0.7× 6 233
Chiemi Hayakawa Japan 10 145 0.6× 94 0.7× 23 0.6× 30 1.1× 2 0.1× 20 350
Marzio Bellan Italy 6 240 1.0× 127 1.0× 36 1.0× 15 0.5× 2 0.1× 6 287
Günther Metz Germany 4 404 1.7× 106 0.8× 69 1.9× 22 0.8× 3 0.1× 6 433

Countries citing papers authored by Omar Hikmat

Since Specialization
Citations

This map shows the geographic impact of Omar Hikmat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Omar Hikmat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Omar Hikmat more than expected).

Fields of papers citing papers by Omar Hikmat

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Omar Hikmat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Omar Hikmat. The network helps show where Omar Hikmat may publish in the future.

Co-authorship network of co-authors of Omar Hikmat

This figure shows the co-authorship network connecting the top 25 collaborators of Omar Hikmat. A scholar is included among the top collaborators of Omar Hikmat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Omar Hikmat. Omar Hikmat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bjørk, Marte‐Helene, et al.. (2025). Obstetric and Neonatal Outcomes in Patients With Maternal Myasthenia Gravis. Neurology. 105(8). e214139–e214139.
2.
Reinson, Karit, Marcello Bellusci, Julien H. Park, et al.. (2024). Current global vitamin and cofactor prescribing practices for primary mitochondrial diseases: Results of a European reference network survey. Journal of Inherited Metabolic Disease. 48(1). e12805–e12805. 2 indexed citations
4.
Berland, Siren, Claus Klingenberg, Eylert Brodtkorb, et al.. (2024). Epidemiology and natural history of POLG disease in Norway: a nationwide cohort study. Annals of Clinical and Translational Neurology. 11(7). 1819–1830. 3 indexed citations
5.
Brandström, Per, Johanna Uusimaa, Elsebet Østergaard, et al.. (2022). Renal Phenotype in Mitochondrial Diseases: A Multicenter Study. SHILAP Revista de lepidopterología. 8(2). 148–159. 8 indexed citations
6.
Varhaug, Kristin N., Omar Hikmat, & Laurence A. Bindoff. (2022). Mitokondriesykdom forårsaket av m.3243A>G-mutasjonen. Tidsskrift for Den norske legeforening. 1 indexed citations
7.
Vissing, John, Elsebet Østergaard, Laurence A. Bindoff, et al.. (2021). Phenotypic spectrum and clinical course of single large-scale mitochondrial DNA deletion disease in the paediatric population: a multicentre study. Journal of Medical Genetics. 60(1). 65–73. 11 indexed citations
8.
Sand, Trond, et al.. (2021). A characteristic occipital epileptiform EEG pattern in ADCK3‐related mitochondrial disease. Epileptic Disorders. 23(2). 281–290. 3 indexed citations
9.
Varhaug, Kristin N., et al.. (2021). Serum biomarkers in primary mitochondrial disorders. Brain Communications. 3(1). fcaa222–fcaa222. 18 indexed citations
10.
Hikmat, Omar, K Naess, Martin Engvall, et al.. (2020). The impact of gender, puberty, and pregnancy in patients with POLG disease. Annals of Clinical and Translational Neurology. 7(10). 2019–2025. 8 indexed citations
11.
Hikmat, Omar, K Naess, Martin Engvall, et al.. (2020). Simplifying the clinical classification of polymerase gamma (POLG) disease based on age of onset; studies using a cohort of 155 cases. Journal of Inherited Metabolic Disease. 43(4). 726–736. 46 indexed citations
12.
Hikmat, Omar, Bente Johanne Vederhus, Claus Klingenberg, et al.. (2020). Mental health and health related quality of life in mitochondrial POLG disease. Mitochondrion. 55. 95–99. 3 indexed citations
13.
Auranen, Mari, Niklas Darín, Kalliopi Sofou, et al.. (2020). Diagnostic value of serum biomarkers FGF21 and GDF15 compared to muscle sample in mitochondrial disease. Journal of Inherited Metabolic Disease. 44(2). 469–480. 40 indexed citations
14.
Hikmat, Omar, Kristin N. Varhaug, & Laurence A. Bindoff. (2020). Polymerase gamma-relatert mitokondriesykdom. Tidsskrift for Den norske legeforening. 140(1). 1 indexed citations
15.
Hikmat, Omar, K Naess, Martin Engvall, et al.. (2018). Elevated cerebrospinal fluid protein in POLG‐related epilepsy: Diagnostic and prognostic implications. Epilepsia. 59(8). 1595–1602. 6 indexed citations
16.
Hikmat, Omar, Charalampos Tzoulis, W.K. Chong, et al.. (2017). The clinical spectrum and natural history of early-onset diseases due to DNA polymerase gamma mutations. Genetics in Medicine. 19(11). 1217–1225. 41 indexed citations
17.
Hikmat, Omar, Tom Eichele, Charalampos Tzoulis, & Laurence A. Bindoff. (2017). Understanding the Epilepsy in POLG Related Disease. International Journal of Molecular Sciences. 18(9). 1845–1845. 36 indexed citations
18.
Hikmat, Omar, Charalampos Tzoulis, Claus Klingenberg, et al.. (2017). The presence of anaemia negatively influences survival in patients with POLG disease. Journal of Inherited Metabolic Disease. 40(6). 861–866. 12 indexed citations
19.
Hikmat, Omar, Charalampos Tzoulis, P.M. Knappskog, et al.. (2016). ADCK3 mutations with epilepsy, stroke‐like episodes and ataxia: a POLG mimic?. European Journal of Neurology. 23(7). 1188–1194. 39 indexed citations
20.
Elgen, Irene Bircow, et al.. (2013). CFS in Children and Adolescent: Ten Years of Retrospective Clinical Evaluation. International Journal of Pediatrics. 2013. 1–5. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026